Brian J. Brille - 17 Jun 2025 Form 3 Insider Report for Caris Life Sciences, Inc.

Role
Exhibit 24 - Power of Attorney. Vice Chairman and Executive Vice President, Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI on Nasdaq
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
3
Filing time
17 Jun 2025, 21:31:18 UTC
Next filing
23 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brille Brian J Exhibit 24 - Power of Attorney. Vice Chairman and Executive Vice President, Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 17 Jun 2025 0002071959

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAI Common Stock 500,000 17 Jun 2025 By Trusts F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAI Stock Option 17 Jun 2025 Common Stock 2,000,000 $2.44 Direct F2
holding CAI Stock Option 17 Jun 2025 Common Stock 1,000,000 $8.00 Direct F2
holding CAI Stock Option 17 Jun 2025 Common Stock 437,500 $16.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F2 The stock option is fully vested and exercisable.
F3 The stock option vests in five substantially equal annual installments beginning on August 11, 2022.

Remarks:

Exhibit 24 - Power of Attorney. Vice Chairman and Executive Vice President